Introduction and WHO perspective on the global burden of musculoskeletal conditions.
Reginster
J Y
JY
WHO Collaborating Centre for Public Health Aspects of Rheumatic Disorders, University of Liège, B-4020 Liège, Belgium.
Khaltaev
N G
NG
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000453:epidemiology*; D017281:Cost of Illness; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy / Q000453:epidemiology*; D010146:Pain / Q000188:drug therapy; D011788:Quality of Life; D012720:Severity of Illness Index; D014944:World Health Organization
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors